Accelerating pooled licensing of medicines to enhance global production and equitable access.
作者信息
Shadlen Kenneth C
机构信息
Department of International Development, London School of Economics and Political Science, London, UK.
出版信息
Lancet. 2022 Aug 20;400(10352):632-634. doi: 10.1016/S0140-6736(22)01013-3. Epub 2022 Jul 8.
Abstract
摘要
相似文献
1
Accelerating pooled licensing of medicines to enhance global production and equitable access.加快药品集中许可以提高全球产量并促进公平获取。
Lancet. 2022 Aug 20;400(10352):632-634. doi: 10.1016/S0140-6736(22)01013-3. Epub 2022 Jul 8.
2
Compulsory licensing of pharmaceuticals reconsidered: Current situation and implications for access to medicines.重新考虑药品的强制许可：现状及其对药品可及性的影响。
Glob Public Health. 2018 Oct;13(10):1430-1440. doi: 10.1080/17441692.2017.1407811. Epub 2017 Nov 28.
3
Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?非洲的药品获取与丙型肝炎：分级定价和自愿许可能否确保普遍获取、健康公平与公正？
Global Health. 2017 Sep 13;13(1):73. doi: 10.1186/s12992-017-0297-6.
4
Taking TRIPS to India--Novartis, patent law, and access to medicines.前往印度的《与贸易有关的知识产权协定》之行——诺华公司、专利法与药品可及性
N Engl J Med. 2007 Feb 8;356(6):541-3. doi: 10.1056/NEJMp068245.
5
6
The global health licensing program: a new model for humanitarian licensing at the university level.
Am J Law Med. 2009;35(2-3):281-309. doi: 10.1177/009885880903500203.
7
Learning from practice: compulsory licensing cases and access to medicines.从实践中学习：强制许可案例与药品可及性
Pharm Pat Anal. 2012 Nov;1(5):555-75. doi: 10.4155/ppa.12.68.
8
Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region.改善世界卫生组织东南亚区域基本癌症药物可及性的方法。
WHO South East Asia J Public Health. 2018 Sep;7(2):62-66. doi: 10.4103/2224-3151.239415.
9
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
10
Commentary: Fulfilling the Promise of Global Access Licensing Principles to Enable Equitable Access.评论：履行全球准入许可原则的承诺，以实现公平准入。
Healthc Policy. 2022 May;17(4):37-44. doi: 10.12927/hcpol.2022.26828.
引用本文的文献
1
Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets.72个低收入、中等收入和高收入市场基本药物的价格与可负担性
JAMA Health Forum. 2025 Aug 1;6(8):e252043. doi: 10.1001/jamahealthforum.2025.2043.
2
Embedding a commitment to equitable global access into basic and early-phase translational research.将对公平全球获取的承诺融入基础和早期转化研究中。
J Clin Transl Sci. 2025 Feb 25;9(1):e88. doi: 10.1017/cts.2024.691. eCollection 2025.
3
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response.COVID-19 危机期间治疗方法的知识产权许可：对大流行防范和应对的经验教训。
Global Health. 2024 Jul 2;20(1):52. doi: 10.1186/s12992-024-01057-5.
4
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries.在低收入和中等收入国家实现单克隆抗体公平可及的新方法。
PLOS Glob Public Health. 2024 Jul 1;4(7):e0003418. doi: 10.1371/journal.pgph.0003418. eCollection 2024.
5
Life Science 2.0: reframing the life science sector for 'the benefit on mankind'.生命科学 2.0：为“造福人类”重新构建生命科学领域
Glob Health Action. 2024 Dec 31;17(1):2330758. doi: 10.1080/16549716.2024.2330758. Epub 2024 Apr 5.
6
Shaping the future of global access to safe, effective, appropriate and quality health products.塑造全球获取安全、有效、适宜和优质健康产品的未来。
BMJ Glob Health. 2024 Jan 9;9(1):e014425. doi: 10.1136/bmjgh-2023-014425.
7
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story.谈判公共卫生知识产权许可协议以增加卫生技术的获取：内幕故事。
BMJ Glob Health. 2023 Sep;8(9). doi: 10.1136/bmjgh-2023-012964.
8
Affordable Cystic Fibrosis (CF) Transmembrane Conductance Regulator Modulator Drugs for CF: All CF Lives Worldwide Matter!用于囊性纤维化（CF）的价格亲民的囊性纤维化跨膜传导调节因子调节剂药物：全球所有囊性纤维化患者的生命都至关重要！
Am J Respir Crit Care Med. 2023 Nov 1;208(9):915-916. doi: 10.1164/rccm.202307-1200VP.
9
Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!囊性纤维化跨膜传导调节因子调节剂药物可及性方面的现实世界差异与伦理考量：关注差距！
Front Pharmacol. 2023 Mar 27;14:1163391. doi: 10.3389/fphar.2023.1163391. eCollection 2023.
本文引用的文献
1
Global drug diffusion and innovation with the medicines patent pool.药品专利池与全球药品扩散和创新。
J Health Econ. 2022 Sep;85:102671. doi: 10.1016/j.jhealeco.2022.102671. Epub 2022 Aug 14.
2
It is not too late to achieve global covid-19 vaccine equity.实现全球新冠疫苗公平分配还为时不晚。
BMJ. 2022 Mar 24;376:e070650. doi: 10.1136/bmj-2022-070650.
3
How COVID-19 vaccine supply chains emerged in the midst of a pandemic.新冠疫情期间新冠疫苗供应链是如何形成的。
World Econ. 2022 Feb;45(2):468-522. doi: 10.1111/twec.13183. Epub 2021 Oct 28.
4
Patent pooling to increase access to essential medicines.专利池以增加基本药物的可及性。
Bull World Health Organ. 2019 Aug 1;97(8):575-577. doi: 10.2471/BLT.18.229179. Epub 2019 Jun 11.
5
Essential medicines for universal health coverage.全民健康覆盖的基本药物。
Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8.
6
Implementing socially responsible licensing for global health: beyond neglected diseases.实施对全球健康负责任的许可：超越被忽视的疾病。
Sci Transl Med. 2014 Oct 29;6(260):260cm11. doi: 10.1126/scitranslmed.3009422.
7
The silent epidemic of exclusive university licensing policies on compounds for neglected diseases and beyond.针对被忽视疾病及其他疾病的化合物，高校独家许可政策的无声蔓延。
PLoS Negl Trop Dis. 2010 Mar 30;4(3):e570. doi: 10.1371/journal.pntd.0000570.
8
The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good.国际药品采购机制专利池倡议：汇聚专利，造福大众。
Open AIDS J. 2010 Jan 19;4:37-40. doi: 10.2174/1874613601004020037.
9
Towards a Patent Pool for HIV Medicines: The Background.迈向艾滋病药物专利池：背景
Open AIDS J. 2010 Jan 19;4:33-6. doi: 10.2174/1874613601004020033.
Zotero 插件